INDEPENDENT THINKING. WHOLE-FOOD LIVING.NO ANIMALS / NO OIL
THENANODIET
← THE STUDY LIBRARY

Systematic review / meta-analysis / 2019

Echinacea might have a preventative effect on respiratory tract infection incidence, but evidence does not show an effect on illness duration.

A systematic review and meta-analysis of randomised double-blind placebo-controlled trials evaluated echinacea preparations for upper respiratory tract infections. For prevention, echinacea was associated with a risk ratio of 0.78 (95% CI 0.68-0.88), while treatment showed a mean difference in duration of -0.45 days (95% CI 1.85-0.94), and safety analysis yielded a risk ratio of 1.09 (95% CI 0.95-1.25). The authors concluded echinacea might have a preventative effect on incidence, though whether it is clinically meaningful is debatable, and no evidence was found for an effect on duration. Findings are limited by clinical heterogeneity, risk of selective reporting, protocol deviations, and lack of author contact.

Study type
Systematic review and meta-analysis of RCTs
Who was studied
Otherwise healthy participants of any age and sex
What was measured
Prevention (incidence), duration, and safety of upper respiratory tract infections

THE PAPER

Echinacea for the prevention and treatment of upper respiratory tract infections: A systematic review and meta-analysis.

David S, Cunningham R. Complement Ther Med, 2019.

PubMed 31126553 ↗DOI 10.1016/j.ctim.2019.03.011 ↗

Other health

This note is written from the study's published abstract. It summarizes what the authors reported; it is not medical advice and does not replace reading the full paper.